An informative study on the Pulmonary Arterial Hypertension (PAH) Market from 2020-2027 has lately released for the database of Coherent Market Insights that helps by making business conclusions and shape the future of the organizations. Individual analysis of top regions and countries like North America, Europe, Asia-Pacific, South America, Asia-Pacific, Middle East & Africa and Latin America and the rest of the world is conducted. Industry overview, product definitions, and growth status are presented Continue reading →

November 26, 2020 12:50 ET | Source: insightSLICE PUNE, India, Nov. 26, 2020 (GLOBE NEWSWIRE) -- The Global Pharmacovigilance Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research & development activities, supply chain analysis, competitive landscape, and market composition analysis. The pharmacovigilance market size was estimated to be US$ 4.2 billion and is expected to reach US$ 18.7 billion by 2030 at a CAGR of 14.6% through 2030 Continue reading →

DUBLIN--(BUSINESS WIRE)--The "Acromegaly and Gigantism - Epidemiology Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. Continue reading →

A new research document with title Global Hypertension And Heart Failure Treatment Market Report covering detailed analysis, Competitive landscape, forecast and strategies has been added to the Insight Partners. The study covers geographic analysis that includes regions like North America, Europe and Asia-Pacific, South America, Middle East and Africa. The report will help user gain market insights, future trends and growth prospects for forecast to 2027. Continue reading →

Closed Loop Medicine has recruited its first patient into a novel PhIV precision medicine interventional clinical trial for patients with high blood pressure. The UK clinical stage therapeutics company is developing drug + digital combination products. Continue reading →

About 35 percent of Americans have metabolic syndrome, a group of risk factors that raises the risk of cardiovascular disease the leading cause of death in the United States. Continue reading →

In this Phase 2, multicenter, randomized, double-blind study (NCT02702388), 152 patients with RAI-refractory DTC were randomized to receive a daily oral dose of either 24 mg or 18 mg of LENVIMA. Continue reading →

UpMarketResearch, one of the worlds prominent market research firms has announced a novel report on the Pulmonary Arterial Hypertension (PAH) market. Continue reading →

Global Pulmonary Arterial Hypertension (PAH) Market 2025 Report Provides Porters Five Forces Analysis Illustrates the Potency of Buyers & Suppliers Operating in the Industry & the Quantitative Analysis of The Global Market from 2019 to 2025 is Provided to Determine the Market Potential. Continue reading →